CBIO
Crescent Biopharma, Inc.
14.30$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| – | 233.0% | – | – | – | – | – | – | 5.3% | 0.5% | – | – | – | |
| – | 100.0% | – | – | – | – | – | – | 94.7% | 100.0% | 100.0% | – | – | |
| – | 52,884.5% | – | – | – | – | – | – | 66.6% | 876.3% | 1,723.1% | – | 359.7% | |
| – | 43,120.0% | – | – | – | – | – | – | 18.1% | 67.4% | 757.0% | – | 69.4% | |
| – | 96,008.3% | – | – | – | – | – | – | 84.7% | 943.7% | 2,480.1% | – | 424.9% | |
| – | -95,908.3% | – | – | – | – | – | – | -84.7% | -843.7% | -2,380.1% | – | -396.9% | |
| – | – | – | – | – | – | – | – | 0.0% | 30.0% | 0.0% | – | 7.7% | |
| – | -90,782.6% | – | – | – | – | – | – | -80.5% | -833.6% | -2,240.9% | – | -384.3% | |
| – | – | – | – | – | – | – | – | – | 18.4% | – | – | – | |
| – | -90,786.4% | – | – | – | – | – | – | -80.5% | -852.1% | -2,240.9% | – | -384.0% | |
| – | -95,671.6% | – | – | – | – | – | – | -80.4% | -833.1% | -2,234.7% | – | -383.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.